T Rankinen, A Zuberi, YC Chagnon, SJ … - Obesity, 2006 - pbrc.edu Abstract RANKINEN, TUOMO, AAMIR ZUBERI, YVON C. CHAGNON, S. JOHN WEISNAGEL,
GEORGE ARGYROPOULOS, BRANDON WALTS, LOUIS PE´RUSSE, AND CLAUDE BOUCHARD. The
human obesity gene map: the 2005 update. Obesity. 2006;14: 529–644. This ... Cited by 332 - Related articles - View as HTML - All 6 versions
EE Snyder, B Walts, L Pérusse, YC Chagnon, … - update, 2004 - Citeseer WEISNAGEL, TUOMO RANKINEN, AND CLAUDE BOUCHARD. The human obesity gene map: the
2003 update. Obes Res. 2004;12:369–439. This is the tenth update of the human
obesity gene map, incorporating published results up to the end of October ... Cited by 237 - Related articles - View as HTML - BL Direct - All 7 versions
YC Chagnon, T Rankinen, EE Snyder, SJ … - Obesity, 2003 - nature.com This is the ninth update of the human obesity gene map, incorporating published
results through October 2002 and continuing the previous format. Evidence from
single-gene mutation obesity cases, Mendelian disorders exhibiting obesity ... Cited by 225 - Related articles - BL Direct - All 6 versions
L Perusse, T Rankinen, A Zuberi, YC Chagnon … - Obesity research, 2005 - informatik.hu-berlin.de Abstract PE´ RUSSE, LOUIS, TUOMO RANKINEN, AAMIR ZUBERI, YVON C. CHAGNON, S.
JOHN WEISNAGEL, GEORGE ARGYROPOULOS, BRANDON WALTS, ERIC E. SNYDER, AND CLAUDE
BOUCHARD. The human obesity gene map: the 2004 update. Obes Res. 2005; ... Cited by 210 - Related articles - View as HTML - All 6 versions
- ►aspetjournals.org SL Kirstein, PA Insel - Pharmacological reviews, 2004 - ASPET Pharmacogenetics, the inherited basis for interindividual differences in drug
response, has rapidly expanded with the advent of new molecular tools and the
sequencing of the human genome, yielding pharmacogenomics. We review here ... Cited by 80 - Related articles - BL Direct - All 10 versions
H Hauner, M Meier, KH Jöckel, UH Frey, W … - Pharmacogenetics and Genomics, 2003 - journals.lww.com Background Sibutramine, a centrally acting noradrenaline and serotonin re-uptake
inhibitor, enhances satiety and is frequently used to support weight loss.
However, a significant variability exists among individuals concerning the ... Cited by 57 - Related articles - BL Direct - All 7 versions
W Siffert - Current Hypertension Reports, 2003 - Springer Introduction Essential hypertension affects approximately 25% of indi- viduals
in Western societies, with an increased prevalence in older subjects. It has
long been recognized that a signifi- cant part of the susceptibility for ... Cited by 53 - Related articles - BL Direct - All 7 versions
- ►shouxi.net M Kolak, J Westerbacka, VR Velagapudi, D … - Diabetes, 2007 - Am Diabetes Assoc RESULTS— Expression levels of the macrophage marker CD68, the chemokines
monocyte chemoattractant protein-1 and macrophage inflammatory protein-1α, and
plasminogen activator inhibitor-1 were significantly increased, and those ... Cited by 44 - Related articles - BL Direct - All 10 versions
A Mairal, D Langin, P Arner, J Hoffstedt - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 1629–1636 DOI 10.1007/s00125-006-0272-
x ARTICLE A. Mairal . D. Langin . P. Arner . J. Hoffstedt ... Cited by 38 - Related articles - BL Direct - All 5 versions
- ►nih.gov [PDF] D Rosskopf, I Manthey, C Habich, M Kielbik, A … - Biochemical Journal, 2003 - pubmedcentral.nih.gov The T-allele of a polymorphism (C825T) in the gene for the G-protein β3 subunit
(GNB3) is associated with cardiovascular and metabolic disorders, distinct
cellular features and altered drug responses. The molecular mechanisms that ... Cited by 37 - Related articles - BL Direct - All 9 versions
